Extract from the Register of European Patents

Citations: EP2822599

Cited inSearch
Type:Patent literature
Publication No.:CN101850117  [I]
 (NAT CT FOR VETERINARY BIOLOG ENGINEERING RES) [I] 1,4-14 * paragraph [0018] * * paragraph [0032] *;
Type:Patent literature
Publication No.:WO2008153541  [Y]
 (INFECTIOUS DISEASE RES INST [US]; REED STEVEN G [US]; CARTER DARRICK [) [Y] 6,7,13,14 * example 15 * * example 3 *;
Type:Patent literature
Publication No.:WO2011106100  [IY]
 (UNIV DUKE [US]; HAYNES BARTON F [US]; LIAO HUA-XIN [US]; TOMARAS GEORG) [I] 8-10 * claim 19 * * page 19 * [Y] 6,7,11-14;
Type:Non-patent literature
Publication information:[A]  - BARBARA C BAUDNER ET AL, "MF59 Emulsion Is an Effective Delivery System for a Synthetic TLR4 Agonist (E6020)", PHARMACEUTICAL RESEARCH, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NL, (20090303), vol. 26, no. 6, doi:10.1007/S11095-009-9859-5, ISSN 1573-904X, pages 1477 - 1485, XP019686195 [A] 1,4-14 * figure 2. *
DOI: http://dx.doi.org/10.1007/s11095-009-9859-5
Type:Non-patent literature
Publication information:[A]  - MA R ET AL, "Additive effects of CpG ODN and R-848 as adjuvants on augmenting immune responses to HBsAg vaccination", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 361, no. 2, doi:10.1016/J.BBRC.2007.07.028, ISSN 0006-291X, (20070921), pages 537 - 542, (20070806), XP027016351 [A] 1,4-14 * the whole document *
DOI: http://dx.doi.org/10.1016/j.bbrc.2007.07.028
Type:Non-patent literature
Publication information:[A]  - NAPOLITANI GIORGIO ET AL, "Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells", NATURE IMMUNOLOGY, NATURE PUBLISHING GROUP, GB, (20050801), vol. 6, no. 8, doi:10.1038/NI1223, ISSN 1529-2908, pages 769 - 776, XP002442459 [A] 1,4-14 * the whole document *
DOI: http://dx.doi.org/10.1038/ni1223
Type:Non-patent literature
Publication information:[XY]  - BALDWIN S L ET AL, "Intradermal immunization improves protective efficacy of a novel TB vaccine candidate", VACCINE, ELSEVIER LTD, GB, vol. 27, no. 23, doi:10.1016/J.VACCINE.2009.03.018, ISSN 0264-410X, (20090518), pages 3063 - 3071, (20090326), XP026058724 [X] 2,3,6-13 * figure 1 * [Y] 4,5,14
DOI: http://dx.doi.org/10.1016/j.vaccine.2009.03.018
Type:Non-patent literature
Publication information:[A]  - BALDWIN S L ET AL, "Enhanced humoral and Type 1 cellular immune responses with Fluzone<(>R) adjuvanted with a synthetic TLR4 agonist formulated in an emulsion", VACCINE, ELSEVIER LTD, GB, vol. 27, no. 43, doi:10.1016/J.VACCINE.2009.07.081, ISSN 0264-410X, (20091009), pages 5956 - 5963, (20090811), XP026643892 [A] 2,3,6-13 * paragraph [02.3] *
DOI: http://dx.doi.org/10.1016/j.vaccine.2009.07.081
Type:Non-patent literature
Publication information:[Y]  - OTT G ET AL, "MF59. DESIGN AND EVALUATION OF A SAFE AND POTENT ADJUVANT FOR HUMAN VACCINES", PHARMACEUTICAL BIOTECHNOLOGY, KLUWER, DORDRECHT, NL, (19950101), vol. 6, ISSN 1078-0467, pages 277 - 296, XP001206665 [Y] 4,5,14 * page 191 *
Type:Non-patent literature
Publication information:[Y]  - KONG L ET AL, "Expression-System-Dependent Modulation of HIV-1 Envelope Glycoprotein Antigenicity and Immunogenicity", JOURNAL OF MOLECULAR BIOLOGY, ACADEMIC PRESS, UNITED KINGDOM, vol. 403, no. 1, doi:10.1016/J.JMB.2010.08.033, ISSN 0022-2836, (20101015), pages 131 - 147, (20100825), XP027363319 [Y] 11,12 * figure 7 *
DOI: http://dx.doi.org/10.1016/j.jmb.2010.08.033
Type:Non-patent literature
Publication information:[T]  - M. A. MOODY ET AL, "Toll-Like Receptor 7/8 (TLR7/8) and TLR9 Agonists Cooperate To Enhance HIV-1 Envelope Antibody Responses in Rhesus Macaques", JOURNAL OF VIROLOGY., US, (20140315), vol. 88, no. 6, doi:10.1128/JVI.03309-13, ISSN 0022-538X, pages 3329 - 3339, XP055226269 [T] * the whole document *
DOI: http://dx.doi.org/10.1128/JVI.03309-13
Cited inInternational search
Type:Patent literature
Publication No.:WO2011106100  [X]
 (DUKE UNIVERSITY);
Type:Patent literature
Publication No.:US2012039916  [A]
 (ZURAWSKI, G. ET AL.);
Type:Patent literature
Publication No.:US2010047331  [A]
 (HAYNES, B. F. ET AL.)
Type:Non-patent literature
Publication information:[Y]  - KONG, L. ET AL., "Expression-System-Dependent Modulation of HIV-1 Envelope Glycoprotein Antigenicity and Immunogenicity", JOURNAL OF MOLECULAR BIOLOGY, (2010), vol. 403, pages 131 - 147, XP027363319
DOI: http://dx.doi.org/10.1016/j.jmb.2010.08.033
Type:Non-patent literature
Publication information:[A]  - WILLE-REECE, U. ET AL., "Immunization with HIV-1 Gag Protein Conjugated to a TLR7/8 Agonist Results in the Generation of HIV-1 Gag-Specific Th1 and CD8+ T Cell Responses", THE JOURNAL OF IMMUNOLOGY, (2005), vol. 174, no. 12, pages 7676 - 7683, XP002545301
Type:Non-patent literature
Publication information:[A]  - KORNBLUTH, R. S. ET AL., "Immunostimulatory Combinations: Designing the Next Generation of Vaccine Adjuvants", JOURNAL OF LEUKOCYTE BIOLOGY, (2006), vol. 80, pages 1084 - 1102, XP002584239
Cited inby applicant
Type:Patent literature
Publication No.:US5709879  
Type:Patent literature
Publication No.:US6451352  
Type:Non-patent literature
Publication information:   - BIOTECHNOLOGY, (1995), vol. 6, pages 141 - 228
Type:Non-patent literature
Publication information:   - KWISSA ET AL., BLOOD, (2012), vol. 119, pages 2044 - 55
Type:Non-patent literature
Publication information:   - POCKROS ET AL., GASTROENTEROLOGY, (2003), vol. 124, page A766
Type:Non-patent literature
Publication information:   - POCKROS ET AL., J. HEPATOL., (2007), vol. 47, no. 2, pages 174 - 182
Type:Non-patent literature
Publication information:   - VACARI ET AL., ANTIVIRAL THERAPY, (2007), vol. 12, pages 741 - 751